These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2448783)

  • 1. Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.
    Stafford HA; Tykocinski ML; Lublin DM; Holers VM; Rosse WF; Atkinson JP; Medof ME
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):880-4. PubMed ID: 2448783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes.
    Carothers DJ; Hazra SV; Andreson SW; Medof ME
    J Clin Invest; 1990 Jan; 85(1):47-54. PubMed ID: 1688570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
    Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIG-A, DAF and proto-oncogene expression in paroxysmal nocturnal haemoglobinuria-associated acute myelogenous leukaemia blasts.
    Stafford HA; Nagarajan S; Weinberg JB; Medof ME
    Br J Haematol; 1995 Jan; 89(1):72-8. PubMed ID: 7530480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
    Telen MJ
    Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
    J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Kinoshita T; Medof ME; Silber R; Nussenzweig V
    J Exp Med; 1985 Jul; 162(1):75-92. PubMed ID: 2409211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.
    Moore JG; Frank MM; Müller-Eberhard HJ; Young NS
    J Exp Med; 1985 Oct; 162(4):1182-92. PubMed ID: 2413153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of glycosyl-phosphatidylinositol anchored proteins on paroxysmal nocturnal haemoglobinuria (PNH) neutrophils and monocytes: heterogeneous deficiency of decay-accelerating factor (DAF) and CD16 on PNH neutrophils.
    Kawakami Z; Ninomiya H; Tomiyama J; Abe T
    Br J Haematol; 1990 Apr; 74(4):508-13. PubMed ID: 1693286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxysmal nocturnal hemoglobinuria and decay-accelerating factor.
    Rosse WF
    Annu Rev Med; 1990; 41():431-6. PubMed ID: 1691902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunocytochemical staining of decay-accelerating factor (DAF) on erythrocytes: paroxysmal nocturnal hemoglobinuria (PNH)].
    Kobayashi T; Nakazawa M; Sato Y; Tomiyama J; Ninomiya H; Abe T; Terasawa T; Shichishima T; Fujita T
    Rinsho Ketsueki; 1992 Feb; 33(2):162-6. PubMed ID: 1378912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo.
    Devine DV; Siegel RS; Rosse WF
    J Clin Invest; 1987 Jan; 79(1):131-7. PubMed ID: 2432087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
    Nishimura J; Murakami Y; Kinoshita T
    Am J Hematol; 1999 Nov; 62(3):175-82. PubMed ID: 10539884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.
    Sun X; Funk CD; Deng C; Sahu A; Lambris JD; Song WC
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):628-33. PubMed ID: 9892684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different distribution of decay-accelerating factor on hematopoietic progenitors from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Kanamaru A; Okuda K; Ueda E; Kitani T; Kinoshita T; Nagai K
    Blood; 1988 Aug; 72(2):507-11. PubMed ID: 2456796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decay-accelerating factor (DAF) on the blood cell membranes in patients with paroxysmal nocturnal haemoglobinuria (PNH): measurement by enzyme-linked immunosorbent assay (ELISA).
    Ninomiya H; Abe T; Shichishima T; Terasawa T; Fujita T
    Br J Haematol; 1988 May; 69(1):81-7. PubMed ID: 2454648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
    Ninomiya H; Kobayashi T; Abe T
    Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.